Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7086-7086
Author(s):  
C.-M. Tsai ◽  
C.-H. Chiu ◽  
T.-Y. Chou ◽  
L.-H. Li ◽  
C.-Y. Hsiao ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document